Researchers Suggest Additional Testing of Antidepressant Venlafaxine as Potential Treatment for Fibromyalgia

Researchers Suggest Additional Testing of Antidepressant Venlafaxine as Potential Treatment for Fibromyalgia
shutterstock_234464134Antidepressant medication Venlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI), may be a potential therapy for fibromyalgia. A recent review entitled “A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia” was published in the Journal of Clinical Pharmacy and Therapeutics by Dr. Luke. A. VanderWeide, part of Dr. Katy E. Trinkley’s group from the Katy E. Trinkley Department of Clinical Pharmacy at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Fibromyalgia (FM) occurs approximately in 2% to 8% of the population and is a painful condition, normally accompanied by fatigue, memory problems, and sleep disturbances. The diagnosis of FM is mainly clinical, as specific biomarkers for this condition until now have not been identified. In the U.S., fibromyalgia is noted in approximately 1% and 2% of the
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *